Just the Facts: Recce Pharmaceuticals scores 93% efficacy in Phase II trial

By Proactive Investors / February 17, 2025 / www.youtube.com / Article Link


Recce Pharmaceuticals Ltd has received positive Phase II clinical trial results for RECCE(R) 327 Topical Gel (R327G) in treating ...

Recent News

Market still expecting strong growth for major gold producers
July 27, 2026 / www.canadianminingreport.com

Newmont starts Q2/26 strong, growth expected for gold majors
July 27, 2026 / www.canadianminingreport.com

Gold not the consensus play anymore
July 20, 2026 / www.canadianminingreport.com

Gold stocks drop to lowest levels this year
July 20, 2026 / www.canadianminingreport.com

A rebalancing of gold's ratios versus major commodities
July 14, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok